Perigon Wealth Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
21,964
+1,010
+5% +$85.5K 0.02% 474
2026
Q1
$2.08M Sell
20,954
-371
-2% -$48.4K 0.04% 370
2025
Q4
$2.59M Buy
21,325
+716
+3% +$89.8K 0.05% 314
2025
Q3
$2.31M Buy
20,609
+1,403
+7% +$164K 0.05% 320
2025
Q2
$2.57M Buy
19,206
+386
+2% +$42.4K 0.06% 285
2025
Q1
$1.27M Buy
18,820
+4,543
+32% +$312K 0.03% 399
2024
Q4
$828K Buy
14,277
+9,707
+212% +$904K 0.02% 497
2024
Q3
$717K Buy
4,570
+1,229
+37% +$189K 0.02% 515
2024
Q2
$503K Buy
+3,341
New +$401K 0.01% 531

Other funds holding TMDX

Perigon Wealth Management's TMDX Position: Q2 2026 in Review

Perigon Wealth Management increased its Transmedics (TMDX) stake by 4.8% in Q2 2026, buying an estimated $85.5K and bringing the position to 21,964 shares worth $1.46M. The position accounts for 0.02% of the portfolio, ranked #474.

Perigon Wealth Management first reported a position in TMDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.59M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Perigon Wealth Management held 21,964 shares of Transmedics worth $1.46M as of Q2 2026.
  • Perigon Wealth Management bought 1,010 Transmedics shares in Q2 2026, an estimated $85.5K.
  • Transmedics made up 0.02% of Perigon Wealth Management's portfolio in Q2 2026, its #474 holding.
  • Perigon Wealth Management first reported a position in Transmedics in Q2 2024 and has held it in 9 quarters since.
  • Perigon Wealth Management's Transmedics position peaked at $2.59M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.